following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.

.
.
he has worked with patients under similar circumstances, but is not involved in the first lady’s case.
.
star
.
.

.